Stephen P. Mulligan, M.B., B.S., Ph.D. University of Sydney (Australia)

Stephen Mulligan is Senior Staff Specialist Haematologist at Royal North Shore Hospital, Sydney, Adjunct Associate Professor, School of Molecular and Microbial Biosciences, University of Sydney and Director of Haematology at Symbion Pathology, Sydney. He is co-inventor of a novel immunomicroarray that provides an extensive phenotype for leukaemias. He has a long-standing interest in Chronic Lymphocytic Leukaemia and is the Founder and Chairman of the CLL Australian Research Consortium. He is principal investigator for a number of clinical trials in CLL both in Australia and internationally.